APS is an autoimmune disease that leads to arterial and/or venous thrombosis, recurrent
pregnancy loss and persistently positive aPLs. Patients with clinical manifestations highly …

Antiphospholipid antibodies (aPL) have been associated with recurrent pregnancy losses
(RPL) and other obstetrical complications. The diagnostic criteria for the classical …

Triple positivity (positive Lupus Anticoagulant, anticardiolipin and anti β2-glycoptrotein I
antibodies) identifies the pathogenic autoantibody (anti Domain I of β2-glycoptroteinI) that is …

Antiphospholipid syndrome (APS) is an acquired thrombophilia with clinical manifestations
associated with the presence of antiphospholipid antibodies (aPL) in patient plasma …

Atherothrombosis is the major determinant of acute ischaemic cardiovascular events, such
as myocardial infarction and stroke. Inflammatory processes have been linked to all phases …

Methods We retrospectively evaluated 95 patients according to their rethrombotic status. We
registered anticoagulation (OA) status, comorbidities, traditional thrombotic factors …

Background A major problem for diagnosing the antiphospholipid syndrome (APS) is the
high variability between commercial anti-β2glycoprotein I (β2GPI) assays. Predominantly …

Objective. Currently, 3 antiphospholipid assays are widely used clinically [lupus
anticoagulant (LAC), anticardiolipin (aCL), and anti-ß2-glycoprotein I (anti-ß2-GPI)]. LAC is …

The antiphospholipid syndrome is characterized by thrombosis and recurrent fetal loss in
patients with antiphospholipid antibodies (APLAs). Most pathogenic APLAs are directed …

The antiphospholipid syndrome (APS) is characterized by recurrent vascular thrombosis,
thrombocytopenia, and fetal loss occurring in the presence of antiphospholipid antibodies …